GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Accounts Payable

Renascience (TSE:4889) Accounts Payable : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience Accounts Payable?

Renascience's Accounts Payable for the quarter that ended in Sep. 2024 was 円0.0 Mil.


Renascience Accounts Payable Historical Data

The historical data trend for Renascience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience Accounts Payable Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable
- - - - -

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Renascience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Renascience Accounts Payable Related Terms

Thank you for viewing the detailed overview of Renascience's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Renascience Business Description

Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines